Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

QLTI:US

3.6700 USD 0.0900 2.39%

As of 20:10:00 ET on 06/01/2015.

Company Profile for QLT Inc (QLTI)

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Contact Information

QLT Inc

887 Great Northern Way
Suite 101
Vancouver, BC V5T 4T5
Canada
Phone: 1-604-707-7000
Fax: 1-604-707-7001

Key Executives for QLT Inc (QLTI)

Jason M AryehChairmanGeoffrey F Cox "Geoff"Interim CEO
Glen IbbottInterim CFO/VP:Finance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil